CRISPR/Cas9 mediated next generation gene therapy in chronic myeloid leukemia: CRISPR/Cas9 and CML. Indian Journal of Experimental Biology (IJEB), [S. l.], v. 63, n. 01, p. 52–65, 2025. DOI: 10.56042/ijeb.v63i01.7040. Disponível em: https://or.niscpr.res.in/index.php/IJEB/article/view/7040. Acesso em: 27 aug. 2026.